HonCode

Go Back   HER2 Support Group Forums > Articles of Interest
Register Gallery FAQ Members List Calendar Search Today's Posts Mark Forums Read

Reply
 
Thread Tools Display Modes
Old 05-28-2014, 01:47 PM   #1
'lizbeth
Senior Member
 
'lizbeth's Avatar
 
Join Date: Apr 2008
Location: Sunny San Diego
Posts: 2,214
Post KRAS-variant associated with breast, ovarian cancer risk

KRAS-variant associated with breast, ovarian cancer risk

  • HemOnc Today, July 25, 2012
Women with hereditary breast and ovarian cancer syndrome who are not carriers of BRCA genes may have a KRAS-variant, according to the results of a recent study.



Women with this syndrome have an increased risk of developing primary breast and ovarian cancer, and although an association with BRCA1 and BRCA2 has been previously established, only about 50% of women with the syndrome are positive for these mutations. Those without them, referred to as uninformative, had previously been thought to have no detectable mutations.
In this study, researchers enrolled 232 women from eight institutions and tested their germline DNA for the KRAS-variant (rs61764370) to determine if there was an association between hereditary breast and ovarian cancer syndrome and the mutation.



Source: Pilarski R. PLoS One. 2012;doi:10.1371/journal.pone.0037891.

The variant was found in 21% of patients, a significantly higher proportion than the average population (15%). Among women in the study who were BRCA1 or BRCA2 positive, the occurrence of the KRAS-variant was similar to that of the general population. However, when uninformative patients were tested, about 27.2% of patients had the KRAS-variant.
The researchers also found an association between KRAS-variant and time from ovarian cancer diagnosis. Those women who were tested for the variant within 2 years of diagnosis had a prevalence of 38.5%, compared with 16.7% in women tested more than 2 years postdiagnosis.
Researchers also found that a majority of women with the KRAS-variant developed breast cancer prior to ovarian cancer.
“It appears that there could have been an opportunity for ovarian cancer prevention through chemoprevention and/or prophylactic oophorectomy for these women,” the researchers wrote.
'lizbeth is offline   Reply With Quote
Reply

Thread Tools
Display Modes

Posting Rules
You may not post new threads
You may not post replies
You may not post attachments
You may not edit your posts

BB code is On
Smilies are On
[IMG] code is On
HTML code is On

Forum Jump


All times are GMT -7. The time now is 12:14 PM.


Powered by vBulletin® Version 3.8.7
Copyright ©2000 - 2024, vBulletin Solutions, Inc.
Copyright HER2 Support Group 2007 - 2021
free webpage hit counter